Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine for myocardial injury in COVID-19
NCT04760821Phase 2Unknown
- Sponsor
- Ministry of Health
- Start
- Dec 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trimetazidine in Myocardial injury, sponsored by Ministry of Health. Status: unknown.
02
Drugs
trimetazidine
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT04760821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04760821.